Blood cancers, Myelodysplastic syndrome (MDS), Myelofibrosis, Polycythaemia, Thrombocythaemia
Open
Phase 1
This study is looking at a new drug called INCB057643 to treat cancers that affect how well the bone marrow works.
It is open to people who have:
features of myelodysplastic syndrome and myeloproliferative neoplasm when diagnosed. This is myelodysplastic/myeloproliferative overlap syndrome.
Recruitment start: 1 September 2020
Recruitment end: 30 May 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Emma Searle
Incyte Corporation
Last reviewed: 15 June 2025
CRUK internal database number: 18044
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
